生物活性 | |||
---|---|---|---|
描述 | 4-Bromo-3-hydroxybenzoic acid (BHOA) is a metabolite of Brocresine and a histidine decarboxylase (HDC) inhibitor with IC50s of 1 mM for both rat fetal and rat gastric HDC, also inhibits aromatic-L-amino acid decarboxylase from hog kidney and rat gastric mucosa in vitro with IC50s of 1 mM for both enzymes[1]. BHOA and antihistamine diphenhydramine (DPHM) were injected intraperitoneally to test their effects on SD-induced (sleep deprivation) vertigo. Upregulated HDC in the vestibular and increased CSF (cerebrospinal fluid) concentration of histamine can be detected in the SD mice, indicating vestibular dysfunction which can be ameliorated by both BHOA and DPHM{Qian S, Wang Y, Zhang X. Inhibiting Histamine Signaling Ameliorates Vertigo Induced by Sleep Deprivation. J Mol Neurosci. 2019 Mar;67(3):411-417|https://pubmed.ncbi.nlm.nih.gov/30644035}}. |
实验方案 | |||
---|---|---|---|
1mg | 5mg | 10mg | |
1 mM 5 mM 10 mM |
4.61mL 0.92mL 0.46mL |
23.04mL 4.61mL 2.30mL |
46.08mL 9.22mL 4.61mL |
参考文献 |
---|